Chun Wu
Fortuna: 59 M $ al 31/08/2026
Fortuna: 59 M $ al 31/08/2026
Dr. Chun Wu is on the Board of Directors at BeBetter Med, Inc. Dr. Wu was previously employed as a Founder by Suzhou Baidao Medical Technology Co., Ltd. He received his doctorate degree from The University of Manchester.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BEBETTER MED, INC. 3,96 % | 28/10/2025 | 16.000.916 ( 3,96 % ) | 59 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BEBETTER MED INC. | Director/Miembro de la Junta | 01/06/2012 |
| Empresas | Cargo | Fin |
|---|---|---|
Suzhou Baidao Medical Technology Co., Ltd.
Suzhou Baidao Medical Technology Co., Ltd. BiotechnologyHealth Technology Engages in research and development of pathology detection products | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeBetter Med, Inc.
BeBetter Med, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops drugs for oncology, autoimmune and metabolic diseases | Health Technology |
Suzhou Baidao Medical Technology Co., Ltd.
Suzhou Baidao Medical Technology Co., Ltd. BiotechnologyHealth Technology Engages in research and development of pathology detection products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.